Biotricity, Inc.
General ticker "BTCY" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $11.4M (TTM average)
Biotricity, Inc. follows the US Stock Market performance with the rate: 22.6%.
Estimated limits based on current volatility of 6.4%: low 0.46$, high 0.52$
Factors to consider:
- Total employees count: 55 as of 2023
- Top business risk factors: Pandemic risks, Climate change and natural disasters, Limited operating history, Data processing system interruptions, Insufficient funding
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [0.52$, 1.69$]
- 2025-03-31 to 2026-03-31 estimated range: [0.46$, 1.49$]
Financial Metrics affecting the BTCY estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -52.13 <= 0.33
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -504.44 <= 18.93
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
Short-term BTCY quotes
Long-term BTCY plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $7.65MM | $9.64MM | $12.06MM |
| Operating Expenses | $24.39MM | $25.05MM | $20.89MM |
| Operating Income | $-16.74MM | $-15.41MM | $-8.83MM |
| Non-Operating Income | $-12.39MM | $-3.25MM | $-5.27MM |
| Interest Expense | $1.28MM | $1.84MM | $3.02MM |
| R&D Expense | $2.74MM | $3.23MM | $2.57MM |
| Income(Loss) | $-29.13MM | $-18.66MM | $-14.09MM |
| Profit(Loss)* | $-29.13MM | $-18.66MM | $-14.09MM |
| Stockholders Equity | $-2.14MM | $-19.85MM | $-29.98MM |
| Inventory | $0.84MM | $2.34MM | $1.88MM |
| Assets | $16.68MM | $6.51MM | $5.94MM |
| Operating Cash Flow | $-15.16MM | $-13.55MM | $-6.69MM |
| Capital expenditure | $0.03MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.03MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $25.17MM | $2.00MM | $6.74MM |
| Earnings Per Share** | $-3.85 | $-2.15 | $-1.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.